Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease

2016 ◽  
Vol 50 (6) ◽  
pp. 483-489 ◽  
Author(s):  
Casper Steenholdt ◽  
Madeline T. Frederiksen ◽  
Klaus Bendtzen ◽  
Mark A. Ainsworth ◽  
Ole Ø. Thomsen ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Time Course ◽  
Clinical Implications ◽  
Inflammatory Bowel

Clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease

2012 ◽  
Vol 18 (12) ◽  
pp. 2209-2217 ◽  
Author(s):  
Casper Steenholdt ◽  
Magid Al-khalaf ◽  
Jrn Brynskov ◽  
Klaus Bendtzen ◽  
Ole. Thomsen ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Clinical Implications ◽  
Inflammatory Bowel ◽  
Antibody Levels

Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time

2016 ◽  
Vol 52 (3) ◽  
pp. 344-350 ◽  
Author(s):  
Karin Amcoff ◽  
Mats Stridsberg ◽  
Maria Lampinen ◽  
Anders Magnuson ◽  
Marie Carlson ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Disease Activity ◽  
Bowel Disease ◽  
Clinical Implications ◽  
Inflammatory Bowel ◽  
Over Time

Vitamin D in inflammatory bowel disease: From biology to clinical implications

2019 ◽  
Vol 47 ◽  
pp. 102189 ◽  
Author(s):  
Seyed Mostafa Parizadeh ◽  
Reza Jafarzadeh-Esfehani ◽  
Seyed Mahdi Hassanian ◽  
Ali Mottaghi-Moghaddam ◽  
Anahita Ghazaghi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Vitamin D ◽  
Bowel Disease ◽  
Clinical Implications ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document